KALA BIO, Inc.
KALANASDAQ
Healthcare
Biotechnology
$0.17
+0.01(4.1%)
52W $0.16 – $19.63
Quick:
8-K
Mar 4, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Feb 20, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Feb 17, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13D
Feb 6, 2026 (1 months ago)SCHEDULE 13D
SEC filing disclosure
Filing details and context
8-K
Feb 5, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Feb 2, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 23, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G
Jan 13, 2026 (2 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Jan 8, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 6, 2026 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 2, 2026 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Dec 29, 2025 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Dec 16, 2025 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Dec 16, 2025 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Dec 5, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G
Dec 3, 2025 (4 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Nov 25, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Nov 19, 2025 (4 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
SCHEDULE 13G/A
Nov 14, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Nov 14, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active